The National Institute of Allergy and Infectious Diseases (NIAID) is offering the SBIR-Technology Transfer Direct Phase II (R44) grant to support the transition of commercially-viable vaccines and disease products from NIAID research labs to the marketplace. Small Business Concerns are encouraged to apply for this grant, which aims to further develop and commercialize inventions with the help of research expertise from various sources. The Direct-to-Phase II grant mechanism is designed to accelerate technology development and increase opportunities for Small Business Concerns in the field of vaccine and disease product research.
Opportunity ID: 281590
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-AI-16-009 |
Funding Opportunity Title: | NIAID SBIR-Technology Transfer Direct Phase II (R44) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.855 — Allergy and Infectious Diseases Research |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Feb 18, 2016 |
Last Updated Date: | – |
Original Closing Date for Applications: | Jun 23, 2016 |
Current Closing Date for Applications: | Jun 23, 2016 |
Archive Date: | Jul 24, 2016 |
Estimated Total Program Funding: | $2,000,000 |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Small businesses |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | The goal of this Funding Opportunity Announcement (FOA) is to move commercially-viable vaccines and products for treatment and prevention of diseases relevant to NIAID’s mission from NIAID intramural research laboratories into the marketplace. This FOA solicits Small Business Innovation Research (SBIR) grant applications from Small Business Concerns (SBCs) for projects that incorporate the appropriate research expertise (company, NIAID Intramural or external collaborators/consortiums) to further develop and commercialize such inventions. The Direct-to-Phase II grant mechanism is intended to facilitate SBIR-type research and development, to expand research and development opportunities for applicant SBCs, and to enhance the pace of technology development and commercialization. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-16-009.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
There are no related documents on this grant.
Packages
Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-D | Use for due dates on or after May 25, 2016 | PKG00221601 | May 23, 2016 | Jun 23, 2016 | View |
Package 1
Mandatory forms
281590 RR_SF424_2_0-2.0.pdf
281590 PHS398_CoverPageSupplement_3_0-3.0.pdf
281590 RR_OtherProjectInfo_1_3-1.3.pdf
281590 PerformanceSite_2_0-2.0.pdf
281590 RR_KeyPersonExpanded_2_0-2.0.pdf
281590 RR_Budget_1_3-1.3.pdf
281590 PHS398_ResearchPlan_3_0-3.0.pdf
281590 SBIR_STTR_Information_1_1-1.1.pdf
Optional forms
281590 RR_SubawardBudget30_1_3-1.3.pdf
281590 PHS_Inclusion_Enrollment_Report-1.0.pdf
281590 PHS_AssignmentRequestForm-1.0.pdf